Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BSH 2017 | How does a patient’s personal situation affect CLL treatment choice?

Barbara Eichhorst • 27 Mar 2017
BSH 2017
Chronic Lymphocytic Leukemia

Barbara Eichhorst, MD, from the University of Cologne, Cologne, Germany, speaks about the influence of a patient’s personal situation on chronic lymphocytic leukemia (CLL) treatment choice at the 2017 British Society for Haematology (BSH) Annual Scientific Meeting in Brighton, UK. She discusses aspects including travel time to the medical center, underlying comorbidities and tolerability of intravenous infusions. Dr Eichhorst also highlights that it is also important to consider subsequent treatment options.

More from Barbara Eichhorst

1:05
Risk-factors for Richter’s transformation
Barbara Eichhorst • 10 Dec 2023
2:01
Updated follow-up results of the Phase III GAIA/CLL13 trial
Barbara Eichhorst • 10 Dec 2023
2:08
CLL-RT1 trial: primary endpoint analysis of tislelizumab plus zanubrutinib in patients with RT
Barbara Eichhorst • 10 Dec 2023
1:14
Current trials of interest in CLL
Barbara Eichhorst • 7 Oct 2023

Related Videos

3:02
EUPLAGIA-1: Phase I trial of GLPG5201, a CD19 CAR-T product, in R/R CLL and Richter's transformation
Valentin Ortiz-Maldonado • 16 Apr 2024
3:18
A Phase I study of JBH492, an anti-CCR7 antibody-drug conjugate, in lymphoid malignancies
Pau Abrisqueta • 5 Apr 2024
0:44
Early detection and interception across hematological cancers
Irene Ghobrial • 8 Apr 2024
1:21
Monoclonal B-cell lymphocytosis: a disease to be (or not to be)
Paolo Ghia • 7 Apr 2024
The content of VJHemOnc is intended for healthcare professionals